Russian Pharma Sector Analysis

Table of Contents

1. Analyst View

2. Global Pharmaceutical Market

• 2.1 Geographical Performance
• 2.2 Leading Therapy Classes
• 2.3 Leading Companies
• 2.4 Leading Drugs

3. Russia - Demographics & Healthcare Profile

• 3.1 Life Expectancy
• 3.2 Age Breakup
• 3.3 Hospital Beds & Doctors
• 3.4 Healthcare Expenditure

4. Pharmaceutical Market

• 4.1 Market Size & Growth
• 4.2 Comparative Analysis
• 4.3 Commercial Drugs Market
  • 4.3.1 Trends
  • 4.3.2 Imported & Domestic Drugs
  • 4.3.3 RX & OTC Drugs
  • 4.3.4 Sales Structure - By ATC Groups
  • 4.3.5 Leading Companies
  • 4.3.6 Leading Drugs
  • 4.3.7 Price Analysis
• 4.4 State Segment
  • 4.4.1 DLO Reimbursement Programme
    • 4.4.1.1 Imported & Domestic Drugs
    • 4.4.1.2 RX & OTC Drugs
    • 4.4.1.3 Sales Structure - By ATC Groups
    • 4.4.1.4 Leading Companies
    • 4.4.1.5 Leading Drugs
  • 4.4.2 Hospital Segment
    • 4.4.2.1 Imported & Domestic Drugs
    • 4.4.2.2 Leading Companies
    • 4.4.2.3 Leading Drugs
    • 4.4.2.4 Drugs Demand - By Price
• 4.5 Parapharmaceutical Market
  • 4.5.1 Nutritional Supplements Market
    • 4.5.1.1 Imported & Domestic Supplements
    • 4.5.1.2 Leading Supplements
    • 4.5.1.3 Supplement Demand - By Price
• 4.6 New Drugs

5. Industry Analysis

• 5.1 Market Driving Forces
  • 5.1.1 Aging Population
  • 5.1.2 Increasing Volume & Sales of Expensive Drugs
  • 5.1.3 Government Support & Funding
  • 5.1.4 Medical Insurance
  • 5.1.5 Growing Disposable Income
• 5.2 Growth Avenues
  • 5.2.1 Cardiovascular Drugs
  • 5.2.2 HIV Drugs
  • 5.2.3 High Insulin Demand
  • 5.2.4 Cancer Drugs
  • 5.2.5 Foreign Players
  • 5.2.6 Generics
  • 5.2.7 Clinical Trials Market
• 5.3 Market Roadblocks
  • 5.3.1 Declining Population
  • 5.3.2 Low Growth in Spending under DLO Programme
  • 5.3.3 Price Control
  • 5.3.4 Drug Counterfeiting & Weak IPR Regime

6. Future Outlook (2008-2012)

• 6.1 Commercial Drugs Market
• 6.2 State Segment
• 6.3 Parapharmaceutical Market

7. Key Players

• 7.1 Sanofi-Aventis
• 7.2 Novartis International AG
• 7.3 Roche Group
• 7.4 Pfizer Inc
• 7.5 AstraZeneca Plc

List of Figures:

• Figure 2-1: Global - Pharmaceutical Market (in Billion US$), 2002-2007
• Figure 2-2: Global - Growth of Pharmaceutical Market (%), 2002-2007
• Figure 2-3: Global - Pharmaceutical Market* by Region (%), 2007
• Figure 2-4: Global - Top Five Pharmaceutical Companies by Sales & Net Income (in Billion US$), 2007
• Figure 3-1: Russia - Population (in Million), 2002-2007
• Figure 3-2: Russia - Life Expectancy of Male & Female (in Years), 2002-2008E
• Figure 3-3: Russia - Population Breakup by Age (%), 2002-2008E
• Figure 3-4: Russia - Number of Doctors (per ' 000 Population), 2002-2007E
• Figure 3-5: Russia - Number of Hospital Beds (per ' 000 Population), 2002-2007E
• Figure 3-6: Russia - Share of Healthcare Expenditure in GDP (%), 2002-2007E
• Figure 3-7: Russia - Per Capita Healthcare Expenditure (in US$), 2002-2007E
• Figure 4-1: Russia - Pharmaceutical Market (in Million US$), 2006 & 2007
• Figure 4-2: Russia - Share of Key Segments in Pharmaceutical Market (%), 2006 & 2007
• Figure 4-3: Global - Top Pharmaceutical Retail Markets (in Billion US$), 2007
• Figure 4-4: Global - Growth of Top Pharmaceutical Retail Markets (%), 2007
• Figure 4-5: Global - Per Capita Drug Consumption in Top Pharmaceutical Markets (in US$), 2006
• Figure 4-6: Russia - Share of Personal & State Financing in Pharmaceutical Market (%), 2004-2006
• Figure 4-7: Global - Share of Personal & State Financing in Top Pharmaceutical Markets (%), 2006
• Figure 4-8: Russia - Commercial Drugs Market (in Million US$), 2006 & 2007
• Figure 4-9: Russia - Trends in Commercial Drugs Market (%), 2007
• Figure 4-10: Russia - Share of Imported & Domestic Drugs in Commercial Drugs Market by Sales Value (%), 2006 & 2007
• Figure 4-11: Russia - Share of Imported & Domestic Drugs in Commercial Drugs Market by Sales Volume (%), 2006 & 2007
• Figure 4-12: Russia - Share of RX & OTC Drugs in Commercial Drugs Market by Sales Value (%), 2006 & 2007
• Figure 4-13: Russia - Share of RX & OTC Drugs in Commercial Drugs Market by Sales Volume (%), 2006 & 2007
• Figure 4-14: Russia - Growth* of Major ATC Groups in Commercial Drugs Market (%), 2007
• Figure 4-15: Russia - Price Index for Drugs in Commercial Drugs Market (%), 2005-2007
• Figure 4-16: Russia - Price Index for Imported & Domestic Drugs in Commercial Drugs Market (%), 2005-2007
• Figure 4-17: Russia - Consumer Price Index (%), 2007
• Figure 4-18: Russia - State Segment of Pharmaceutical Market (in Million US$), 2006 & 2007
• Figure 4-19: Russia - Consumption under DLO Programme (in Billion US$), 2006* & 2007
• Figure 4-20: Russia - Share of Imported & Domestic Drugs in the DLO List of Full & Trade Name (%), 2007
• Figure 4-21: Russia - Share of Imported & Domestic Drugs under DLO Programme by Sales Value (%), 2006 & 2007
• Figure 4-22: Russia - Share of RX & OTC Drugs under DLO Programme by Sales Value (%), 2006 & 2007
• Figure 4-23: Russia - Share of RX & OTC Drugs under DLO Programme by Sales Volume (%), 2006 & 2007
• Figure 4-24: Russia - Share of ATC Groups under DLO Programme by Sales Value (%), 2006 & 2007
• Figure 4-25: Russia - Share of Imported & Domestic Drugs under Hospital Segment by Sales Value (%), 2006 & 2007
• Figure 4-26: Russia - Share of Imported & Domestic Drugs under Hospital Segment by Sales Volume (%), 2006 & 2007
• Figure 4-27: Russia - Drugs Demand by Price under Hospital Segment (%), 2007
• Figure 4-28: Russia - Parapharmaceutical Market (in Million US$), 2006 & 2007
• Figure 4-29: Russia - Nutritional Supplements Market (in Million US$), 2005 & 2006
• Figure 4-30: Russia - Nutritional Supplements Market (in Million Units), 2005 & 2006
• Figure 4-31: Russia - Share of Imported & Domestic Nutritional Supplements Sales* (%), 2006
• Figure 4-32: Russia - Breakup* of Imported Nutritional Supplements by Country (%), 2006
• Figure 4-33: Russia - Imported & Domestic Nutritional Supplements Demand by Price (%), 2006
• Figure 4-34: Russia - Sales Structure of New Drugs by Value & Volume (%), 2007
• Figure 5-1: Russia - Population aged 65 Years & Above (in Million), 2001-2007
• Figure 5-2: Russia - Commercial Drugs Demand by Price (%), 2006 & 2007
• Figure 5-3: Russia - Structure of Pharmaceutical Market Growth (%), 2007
• Figure 5-4: Russia - Pharmaceutical Market Growth* by Segment (%), 2007
• Figure 5-5: Russia - Personal Disposable Income (in Billion US$), 2002-2007E
• Figure 5-6: Russia - Share of Deaths from Cardiovascular Diseases in Total Deaths (%), 2005 & 2030F
• Figure 5-7: Russia - Number of HIV Patients (in Million), 2003 & 2020F
• Figure 5-8: Russia - Anti-HIV Drugs Import (in Million US$), 2004 & 2005
• Figure 5-9: Russia - Forecast for Number of Diagnosed Diabetes Patients* (in ' 000), 2003 & 2025F
• Figure 5-10: Russia - Insulin Market (in Million US$), 2006E-2008F
• Figure 5-11: Russia - Share of Deaths from Cancer in Total Deaths (%), 2005 & 2030F
• Figure 5-12: Russia - Generic Drugs Market (in Billion Euro), 2006 & 2010F
• Figure 5-13: Russia - Number of Approved Clinical Trials (2001-2006)
• Figure 5-14: Russia - Number of Patients Participating in Clinical Trials (2002 & 2006)
• Figure 5-15: Russia - Clinical Trials by Therapeutic Areas (%), 2007
• Figure 5-16: Russia - Clinical Trials by Sponsor Country (%), 2007
• Figure 5-17: Russia - Forecast for Population (in Million), 2008-2012
• Figure 6-1: Russia - Forecast for Pharmaceutical Market (in Million US$), 2008-2012
• Figure 6-2: Russia - Forecast for Pharmaceutical Market by Segments (%), 2012
• Figure 6-3: Russia- Forecast for Population aged 65 Years & Above (in Million) 2008-2012
• Figure 6-4: Russia - Forecast for Commercial Drugs Segment (in Million US$), 2008-2012
• Figure 6-5: Russia - Forecast for State Segment (in Million US$), 2008-2012
• Figure 6-6: Russia - Forecast for DLO Market (in Billion US$), 2008-2012
• Figure 6-7: Russia - Forecast for Personal Disposable Income (in Billion US$), 2008-2012
• Figure 6-8: Russia - Forecast for Parapharmaceutical Market (in Million US$), 2008-2012

List of Tables:

• Table 2-1: Global - Pharmaceutical Market by Region (in Billion US$), 2007
• Table 2-2: Global - Leading Therapy Classes by Sales (in Billion US$), 2007
• Table 2-3: Global - Leading Drugs by Sales (in Billion US$), 2007
• Table 4-1: Russia - Leading Pharmaceutical Companies by Sales (in Million US$), 2006 & 2007
• Table 4-2: Russia - Sales Structure of ATC Groups in Commercial Drugs Market, 2007
• Table 4-3: Russia - Leading Pharmaceutical Companies in Commercial Drugs Market by Sales (in Million US$), 2006 & 2007
• Table 4-4: Russia - Leading Drugs in Commercial Drugs Market by Sales (in Million US$), 2006 & 2007
• Table 4-5: Russia - Sales Structure of ATC Groups under DLO Programme, 2007
• Table 4-6: Russia - Leading Pharmaceutical Companies under DLO Programme (in Million US$), 2006 & 2007
• Table 4-7: Russia - Leading Drugs under DLO Programme by Sales (in Million US$), 2006 & 2007
• Table 4-8: Russia - Leading Pharmaceutical Companies under Hospital Segment (%), 2007
• Table 4-9: Russia - Leading Drugs under Hospital Segment by Sales (in Million US$), 2007
• Table 4-10: Russia - Leading Nutritional Supplements by Sales (in Million US$), 2005 & 2006
• Table 4-11: Russia - Top 20 New Trade Names on Commercial Market (in ' 000 US$), 2007
• Table 7-1: Sanofi-Aventis - Key Financials (in Million Euro), 2005-2007
• Table 7-2: Novartis International AG - Key Financials (in Million US$), 2005-2007
• Table 7-3: Roche Group - Key Financials (in Million CHF), 2005-2007
• Table 7-4: Pfizer Inc - Key Financials (in Million US$), 2005-2007
• Table 7-5: AstraZeneca Plc - Key Financials (in Million US$), 2005-2007